Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment.
Claveau JS, Murray DL, Dispenzieri A, Kapoor P, Binder M, Buadi F, Dingli D, Fonder A, Gertz M, Gonsalves W, Hayman S, Hobbs M, Hwa YL, Kourelis T, Lacy M, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar V, Kumar SK.
Claveau JS, et al.
Leukemia. 2023 Jan;37(1):1-4. doi: 10.1038/s41375-022-01779-8. Epub 2022 Dec 8.
Leukemia. 2023.
PMID: 36482129
No abstract available.